期刊文献+

Ki-67、P53及PCNA对脑胶质瘤预后的影响 被引量:4

The Relationship Between Ki-67、P53、PCNA and The Prognosis of Gliomas
在线阅读 下载PDF
导出
摘要 目的回顾性分析了51例脑胶质瘤患者的免疫组化检测结果 ,以探讨Ki-67、P53和PC-NA与病理分级的关系,以及它们对脑胶质瘤预后的影响。方法 51例脑胶质瘤患者,接受手术及术后辅助三维适形放射治疗。用免疫组织化学的方法检测病理切片中Ki-67、P53和PCNA的表达情况,分析它们与病理分级的相关性和预后的影响。结果 Ki-67和PCNA的阳性表达与病理分级呈正相关,与生存率呈负相关。P53与病理分级和生存率无相关性。结论 Ki-67、P53和PCNA是否为脑胶质瘤的独立预后因素尚需大量多因素分析结果证实。 Objective To investigate the relationship between Ki-67, P53, PCNA and pathological grades, and the influence of prognosis by analysis of fifty-one gliomas. Methods 51 gliomas received surgery and post-operation three dimensional conformal radiotherapy in our hospital. Expression of Ki-67 、P53 and PC-NA were determined by i mmunohistoehemistry. The relationship between the three marks and pathological grades and the prognostic factors of gliomas were analyzed. Results The positive expressions of Ki-67 and PC-NA were positively association with pathological grades, but negatively correlate with survival rates. And there were no relationship between P53 and pathological grades and survival rates. Conclusion It is necessary to confirm Ki-67 ,P53 and PCNA were the independently prognostic factors of gliomas through multifactor analysis.
出处 《中国现代药物应用》 2012年第19期16-18,共3页 Chinese Journal of Modern Drug Application
关键词 胶质瘤 预后 KI-67 PCNA P53 Gliomas Prognosis Ki-67 PCNA P53
  • 相关文献

参考文献13

  • 1Bauman G, Lote K, Larson D, et al. Pretreatrnent factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys, 1999,45 (4): 923 -929.
  • 2Kogiku M, Ohsawa I, Matsumoto K, ctal. Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor. J Clin Neurosei, 2008, 15 ( 11 ) : 1198 -203.
  • 3Rodriguez-Pereira C, Suarez-Penaranda JM, Vazquez-Salvado M, et al. Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study. J Neurosurg Sci, 2000,44(4 ) :203-9 ; discussion 209-10.
  • 4McKeever PE. Insights about brain tumors gained through immunohistochemistry and in situ hybridization of nuclear and phenotypic markers. J Histochem Cytochem, 1998,46 (5) :585-594.
  • 5袁庆国,松本健一,岩城澈.MGMT和Ki-67在胶质母细胞瘤中的表达对ACNU化疗预后的影响[J].中国神经肿瘤杂志,2006,4(3):200-204. 被引量:4
  • 6Fisher BJ, Naumova E, Leighton CC, et al. Ki-67: a prognostic factor for low-grade glioma?. Int J Radiat Oncol Biol Phys, 2002, 52(4) :996-1001.
  • 7Haas-Kogan DA, Kogan SS, Yount G, et al. p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors. Int J Radiat Oncol Biol Phys, 1999,43 (2) :399-403.
  • 8岳伟英,俞苏寰,李志强,赵世光,陈忠平.TP53突变与胶质瘤恶性进展[J].中国神经肿瘤杂志,2008,6(2):85-90. 被引量:7
  • 9Nieder C, Petersen S, Petersen C, et al. The challenge of p53 as prognostic and predictive factor in gliomas. Cancer Treat Rev, 2000,26( 1 ) :67-73.
  • 10Kontopidis G, Wu SY, Zheleva DI, et al. Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci U S A, 2005,102(6) :1871-1876.

二级参考文献12

共引文献16

同被引文献32

  • 1Mueller W, Hartmann C, Hoffmann A, et al. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets [ J]. Am J Pathol, 2002, 161 : 313 - 319.
  • 2Igle - Donadey F, Mattin - Duvemeuil N, Earle J, et al. Correlations between molecular and radiologic pattern in oligodendroglial tumors [ J ]. Neurology ,2004,63:2360 - 2362.
  • 3Zalatimo O,Zoccoli C M, Patel A, et al. Impact of genetic targets on primary brain tumor therapy: what's ready for prime time [ J ] ? Adv Exp Med Bio1,2013 ,779 :267 - 89.
  • 4Yan W,Zhang W, You G, et al. Molecular classification of gliomas based on whole genome gene expression : a systematic report of 225 samples fi'om the Chinese Glioma Cooperative Group [ J ]. Neuro 0nco1,2012,14(12) :1432 - 1440.
  • 5Viaecoz A, Lekoubou A, Dueray F, et al. Chemotherapy in low - grade gliomas[ J]. Curr Opin 0ne01,2012,24(6) :694 - 701.
  • 6Gupta K, Salunke P. Molecular markers of glioma: an update on recent progress and perspectives [ J]. J Cancer Res Clin Oncol, 2012,138(12) :1971 - 1981.
  • 7Suri V, Jha P, Agm'wal S, et al. Molecular profile of oligoden - drogliomas in young patients [ J ]. Neuro Oncol, 2011,13 ( 10 ) : 1099 - 1106.
  • 8Mueller W, Hartmann C, Hoffmann A, et al. Genetic sig?nature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets[J]' AmJ Pathol, 2002,161 (1) : 313-319.
  • 9Ig le-Donadey F, Mattin-Duve meuil N, EaneJ, et al. Cor?relations between molecular and radiologic pattern in eli?godendroglial rumors]"]]. Neurology, 2004,63 (12) : 2360- 2362.
  • 10Zalatimo 0, Zoccoli CM, Patel A, et al. Impact of genetic targets on primary brain tumor therapy: what's ready for prime time[J]. Adv Exp Med Biol,2013,779:267-289.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部